Department of Preventive Medicine, Zhejiang Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, 818 Fenghua Road, Ningbo, Zhejiang, People's Republic of China.
College of Medicine, Shaoxing University, 508 Huancheng Road, Shaoxing, Zhejiang Province, People's Republic of China.
Exp Mol Med. 2021 May;53(5):772-787. doi: 10.1038/s12276-021-00617-8. Epub 2021 May 17.
Ulcerative colitis (UC) is a chronic recurrent intestinal inflammatory disease characterized by high incidence and young onset age. Recently, there have been some interesting findings in the pathogenesis of UC. The mucus barrier, which is composed of a mucin complex rich in O-glycosylation, not only provides nutrients and habitat for intestinal microbes but also orchestrates the taming of germs. In turn, the gut microbiota modulates the production and secretion of mucins and stratification of the mucus layers. Active bidirectional communication between the microbiota and its 'slimy' partner, the mucus barrier, seems to be a continually performed concerto, maintaining homeostasis of the gut ecological microenvironment. Any abnormalities may induce a disorder in the gut community, thereby causing inflammatory damage. Our review mainly focuses on the complicated communication between the mucus barrier and gut microbiome to explore a promising new avenue for UC therapy.
溃疡性结肠炎(UC)是一种慢性复发性肠道炎症性疾病,具有发病率高、发病年龄早的特点。近年来,UC 的发病机制有了一些有趣的发现。由富含 O-糖基化的粘蛋白复合物组成的黏液屏障不仅为肠道微生物提供营养和栖息地,还协调了对细菌的驯化。反过来,肠道微生物群调节粘蛋白的产生和分泌以及黏液层的分层。微生物群与其“粘稠”伙伴——黏液屏障之间的主动双向交流似乎是一场持续进行的协奏曲,维持着肠道生态微环境的平衡。任何异常都可能导致肠道群落紊乱,从而引起炎症损伤。我们的综述主要关注黏液屏障和肠道微生物组之间复杂的交流,以探索 UC 治疗的有前途的新途径。